← Leaderboards
Sydney Sanderson
Duke University
$64,046
Attributed
$64,046
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.7K · FY2018–19$50K$37.5K$25K$12.5K$0
'18
'19
Funding mix
By agency
NIH$64,046 · 1
By mechanism
F31$64,046 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- John H Sampson$43,413,436
- Jen-Tsan Ashley Chi$7,491,502
- Charles Michael Cotten$5,917,623
- Michael C Fitzgerald$8,416,267
- Matthew D Hirschey$8,669,459
Others in their field
Other Emerging Leaders on “Adjuvant Therapy”
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Jean Kwun · Duke University$5,686,708
- Patrick R Secor · University Of Montana$4,394,600
- Holly Rockweiler · Madorra, Inc.$4,300,000
- Kenneth B. Bader · University Of Chicago$4,178,329
- Alexandra Margaret Lynn Binder · University Of California Los Angeles$4,065,524
Research focus
Adjuvant TherapyAffectAmino AcidsAnabolismBiochemical PathwayBiologicalBiological ModelsCancer CellCancer Cell LineCancerousCancer PatientCancer TherapyCdkn2a GeneCell LineCellsCharacteristicsChromosome DeletionCommon NeoplasmComplicationConsumptionCyclin-Dependent Kinase Inhibitor 2aData SetDependence9p21